Page last updated: 2024-10-28

hexamethonium and Airway Hyper-Responsiveness

hexamethonium has been researched along with Airway Hyper-Responsiveness in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research Excerpts

ExcerptRelevanceReference
"001) of the mean dose-response relationship."1.28Cholinergic mechanisms involved with histamine hyperreactivity in immune rabbit airways challenged with ragweed antigen. ( Ando, RE; Irvin, CG; Larsen, GL; Tanaka, DT, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, DT1
Ando, RE1
Larsen, GL1
Irvin, CG1

Other Studies

1 other study available for hexamethonium and Airway Hyper-Responsiveness

ArticleYear
Cholinergic mechanisms involved with histamine hyperreactivity in immune rabbit airways challenged with ragweed antigen.
    The American review of respiratory disease, 1991, Volume: 144, Issue:1

    Topics: Acetylcholine; Animals; Antigens; Atropine; Bronchi; Ganglionic Blockers; Hemicholinium 3; Hexametho

1991